Home › Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application
 

Keywords :   


Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application

2013-12-30 08:58:17| Biotech - Topix.net

Genzyme , a Sanofi company , announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada for the treatment of relapsing forms of multiple sclerosis.

Tags: complete application response letter

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
28.09Tropical Storm Joyce Forecast Discussion Number 4
More »